Related Experiment Videos
A fully automated light/dark apparatus useful for comparing anxiolytic agents
1Department of Pharmacology, A.H. Robins Company, Incorporated, Richmond, VA 23261-6609.
Pharmacology, Biochemistry, and Behavior
|December 1, 1991
Summary
This study shows an automated light/dark test effectively identifies anxiolytic drugs in mice. Key indicators like time in lit areas help screen for new anxiety treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Anxiety disorders are prevalent, necessitating effective drug discovery methods.
- Traditional behavioral tests for anxiolytic agents can be labor-intensive.
- Automated behavioral assays offer potential for high-throughput screening.
Purpose of the Study:
- To evaluate a fully automated 2-compartment light/dark test for assessing anxiolytic-like activity in mice.
- To determine the reliability of specific behavioral measures, such as time spent in the lit area, as indicators of anxiolytic effects.
- To assess the efficacy of known and putative anxiolytic agents using this automated system.
Main Methods:
- Mice were tested in a fully automated 2-compartment light/dark apparatus.
- Anxiolytic-like effects were indicated by increased activity in the lit area, including time spent, locomotion, and rearing.
- Doses of diazepam, ipsapirone, ondansetron, 8-OH DPAT, N-phenylbiguanide, imipramine, chlorpromazine, and S(+)-amphetamine were administered.
Main Results:
- Diazepam, ipsapirone, ondansetron, and 8-OH DPAT demonstrated significant anxiolytic-like activity at specific dose ranges.
- N-phenylbiguanide, imipramine, chlorpromazine, and S(+)-amphetamine did not show significant antianxiety-like effects.
- Time spent in the lit area was identified as the most consistent and useful measure for assessing antianxiety-like activity.
Conclusions:
- The fully automated light/dark test is a viable tool for identifying anxiolytic-like properties of compounds.
- The system successfully differentiated between effective anxiolytic agents and inactive compounds.
- This automated approach may accelerate the discovery of novel anxiolytic drugs.